Beekman 1802 unveils bioengineered vegan milk for skincare line

Daniela Castillo Monagas

Beekman 1802 has developed the first vegan bio-milk in the beauty industry – a plant-based, reverse-engineered alternative to goat milk ushering in a new future of biotech skin care. This new Shine-Free range with vegan goat milk targets the needs of oily and combination skin and is tailored towards Gen Z to actively balance the skin barrier.

“Not only did we acknowledge that the younger user searches for vegan skincare, we recognized that goat milk is so rich in fatty acids and researched how to create lighter textures with the same composition of nutrients. This is the beauty of biotechnology,” said Jill Scalamandre, CEO at Beekman 1802.

After having researched goat milk science for 15 years, Beekman 1802 most recently conducted a white paper study to identify the exact composition and weight of the 31 nutrients found inside every drop of goat milk. Although Goat milk fatty acids are rich and ultra-hydrating for dry skin, they may be too heavy for those with oily or blemish-prone skin.

Beekman 1802 worked with 20+ chemists and scientists in labs in Colorado and Florida, ALS testing labs (in vivo and in vitro) in California, as well as key biotech companies, Croda & Sederma, to successfully reverse engineer Beekman’s signature goat milk into a 100% vegan form. The result, a lighter formula that balances the skin barrier and microbiome, controls shine while also being safe for those with sensitive skin. 92% of a 26-subject questionnaire, ages 20-30, saw healthy hydration with a reduction in oil and shine when using products as instructed.

“To clone goat milk into a Shine-Free Range, we looked to plant biotech actives that were safe for sensitive skin with great amino acid profiles like goat milk has but with the added benefit of being powerful astringents, and natural degreasers with barrier balancing properties for oily/combo skin without using harsh acids or harsh exfoliants,” commented Ayesha Bshero, Head of Development at Beekman 1802.

- Advertisement -
Ad imageAd image
Share This Article